Replies to post #14735 on Marker Therapeutics Inc (MRKR)

[Rogerthat1]

But nothing fundamental has changed to warrant this increase in SP

So? The point being? Just trying to understand your post.

[tpizzazz24]

If so, news with this bump in sp should push sp past a buck less they all bale. ASCO 2017 we could see $3+. A bit far out for the likes of many. But still a strong possibility. Only saying because I'd expect P2 data from multiple trials. May even have another partnership if they start dotting the i's now

[tpizzazz24]

Blu said countless times his window was 36 months. I hope he is ok. A valued asset to the board.
Best wishes IC